BioLife Solutions Inc.

NASDAQ: BLFS · Real-Time Price · USD
24.48
0.14 (0.58%)
At close: Aug 18, 2025, 3:59 PM
24.50
0.08%
After-hours: Aug 18, 2025, 04:10 PM EDT

BioLife Solutions Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-20.18M -66.43M -139.81M -7.63M
Depreciation & Amortization
5.49M 12.29M 16.47M 12.87M
Stock-Based Compensation
30.92M 31.67M 25.33M 13.96M
Other Working Capital
2.32M 3.09M 1.99M 5.74M
Other Non-Cash Items
-7.96M 8.56M 109.65M -364K
Deferred Income Tax
-64K -62K -5.24M -20.13M
Change in Working Capital
227K 1.47M -14.9M -3.53M
Operating Cash Flow
8.43M -12.5M -8.49M -4.84M
Capital Expenditures
-3.23M -6.38M -10.38M -8.38M
Cash Acquisitions
60.39M n/a n/a 1.56M
Purchase of Investments
-18.41M -27.09M -53.12M -6.37M
Sales Maturities Of Investments
21.92M 56.17M 8.92M 6.37M
Other Investing Acitivies
-2.37M -4.86M -3.54M -5.82M
Investing Cash Flow
58.3M 17.84M -58.12M -12.64M
Debt Repayment
-6.61M -498K 17.84M -2.89M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-377K 845K -1.71M -1.16M
Financial Cash Flow
-6.78M 10.59M 16.32M -2.78M
Net Cash Flow
59.95M 15.96M -50.4M -20.59M
Free Cash Flow
5.2M -18.88M -18.87M -13.22M